1997 news

  • 1 October 1997
    The prime causes of debilitating illness and cancer death among older men - prostatic disease and prostate cancer - will be in the spotlight at a major conference for clinical and scientific experts in York this week.
  • 29 September 1997
    As part of a major programme to improve student accommodation and facilities at York, the University has signed a deal with ACC Telecom to fit telephones in all study bedrooms.

  • 18 September 1997
    Genesis, six buildings for innovative new businesses, is opened today (3 October) by John Robinson, Chairman of Smith & Nephew plc.
  • 14 August 1997
    CBAMS appoints former Fisons R&D Director as Chairman
    CBAMS Ltd, the York-based company centred on a 5 million volt accelerator mass spectrometer, has appointed Dr Peter Johnson to its board as Chairman elect. Dr Johnson, the former worldwide director of research and development for Fisons Pharmaceuticals and Group Main Board Director of Fisons plc, takes up his position in September.
  • 17 July 1997
    A year of outstanding research success
    New research grants totalling £3,212,450 were announced at a meeting of the University of York's Council on 17 July, in a further boost to a year of outstanding success in research.
  • 27 May 1997
    Thirty-two Russian educationalists, including the Head of Curriculum Development at the Russian Academy of Education, visited York from 1 to 9 June to follow up on new developments in the philosophy and methods of teaching design and technology.

  • 23 May 1997
    The Times annual league table of universities published today (23 May) places York in 6th position. Last year York was 7th and it was 8th in 1995.

  • 23 May 1997
    A huge scientific instrument - the Accelerator Mass Spectrometer - which will enable scientists to conduct research which was previously almost impossible, is to be located near York. The first AMS machine in Europe dedicated to biomedical research, it will speed up drug development, cutting significantly the time it takes to identify new drugs to take through to clinical trials.

  • 26 March 1997
    The bone in our skeletons is constantly being turned over - removed and replaced in a process which repairs damage and alters bone mass in response to our needs.

  • 24 March 1997
    Scientists at the University of York and Karo Bio have solved the structure of the estrogen receptor, one of the crucial receptors targeted by drugs in the treatment of a variety of women's health problems.

  • 1 March 1997
    The bone in our skeletons is constantly being turned over - removed and replaced in a process which repairs damage and alters bone mass in response to our needs.
  • 27 February 1997
    The University of York has received a significant increase in its grant for teaching and research from the Higher Education Funding Council for England.